2025 | Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
| CLINICAL AND MOLECULAR HEPATOLOGY |
2025 | Noncontrast Magnetic Resonance Imaging vs Ultrasonography for Hepatocellular Carcinoma Surveillance: A Randomized, Single-Center Trial | GASTROENTEROLOGY |
2025 | Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated Cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2025 | Editorial: How to Interpret Clinical Impact of Viral Replication Activity for Postoperative Recurrence of HBV-Related HCC | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2025 | Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP-1RA in CHB and T2DM Patients | LIVER INTERNATIONAL |
2025 | Statin use and liver-related prognosis among patients with MASLD
| JHEP REPORTS |
2025 | Association between early job loss and prognosis among hepatocellular carcinoma survivors | OCCUPATIONAL MEDICINE-OXFORD |
2025 | Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2025 | Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
| CANCERS |
2025 | A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B | JOURNAL OF HEPATOLOGY |
2025 | Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness
| CLINICAL AND MOLECULAR HEPATOLOGY |
2025 | Is liver resection still required for patients who have predictive factors for complete pathologic necrosis after downstaging treatments of locally advanced hepatocellular carcinoma? | EJSO |
2024 | Incidence of metabolic dysfunction-associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2024 | 간섬유화 평가를 위한 혈청 표지자의 종류와 의미
| Korean Journal of Gastroenterology |
2024 | Reply to correspondence on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
| CLINICAL AND MOLECULAR HEPATOLOGY |
2024 | Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with longterm antiviral therapy in chronic hepatitis B patients”
| CLINICAL AND MOLECULAR HEPATOLOGY |
2024 | Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere | CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY |
2024 | The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases
| Journal of Liver Cancer(대한간암학회지) |
2024 | KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
| CLINICAL AND MOLECULAR HEPATOLOGY |
2024 | Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study
| CANCERS |
2024 | Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
| PLOS ONE |
2024 | Hepatitis B Reactivation and Vaccination Effectiveness after Solid Organ Transplantation: A Matched Case-Control Study
| VACCINES |
2024 | Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2024 | Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
| CLINICAL AND MOLECULAR HEPATOLOGY |
2024 | Editorial: High qHBsAg—is it a good or bad signal? | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2024 | Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2024 | Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation | HEPATOLOGY INTERNATIONAL |
2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2024 | Metastatic papillary renal cell carcinoma with portal vein tumor thrombosis confirmed on blind liver biopsy
| Journal of Liver Cancer(대한간암학회지) |
2024 | A Liver Stiffness-Based Etiology-Independent Machine Learning Algorithm to Predict Hepatocellular Carcinoma | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2024 | Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2024 | Causal Analyses of Statin to Prevent Liver Disease Progression: A Nationwide Study Using Superlearning Targeted Maximum Likelihood Estimation
| 약학회지 |
2024 | The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
| GUT AND LIVER |
2024 | Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease | GUT AND LIVER |
2023 | Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
| JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION |
2023 | Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study | HEPATOLOGY |
2023 | Association of Alcohol Consumption With Liver Cancer and All-Cause Mortality in Chronic Hepatitis B Patients Without Cirrhosis | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
2023 | Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2023 | Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials
| LIVER CANCER |
2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2023 | ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2023 | How to deliver palliative care for patients with management in decompensated cirrhosis
| HEPATOBILIARY SURGERY AND NUTRITION |
2023 | Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2023 | A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2023 | Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2023 | UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2023 | Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2023 | Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis
| CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2023 | The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |